Quanta Pharma BPC-157 5mg is a synthetic pentadecapeptide derived from human gastric juice. Researched extensively for tissue repair, gut healing, and recovery support. This stable peptide demonstrates remarkable effects on tendons, ligaments, muscles, and the gastrointestinal system. Lab verified 99.76% purity with 5.21mg actual content.

Independently Lab Verified

One new finished product test plus an independent blind screen

Reports

Labs

99%+

Purity

Finished Product Test (Sealed Vial)

New Just Tested

ANALIZA BIAŁEK

Actual Content

Label Claim

Purity

Sample:

Sealed lyophilised vial  |

Order:

100016869  |

Method:

HPLC (BioBasic 8 Thermo Scientific)  |

Verification Key:

Q5HK12D8

Tested 7 August 2026

Independent Blind Screen

JANOSHIK

Actual Content

Label Claim

Purity

Sample:

Sealed lyophilised vial  |

Method:

Blind Screen  |

Tested:

September 2025  |

Verification Key:

K1CE4JZ56AKZ

Quanta Pharma BPC-157 5mg

is a pharmaceutical-grade

synthetic pentadecapeptide

derived from human gastric juice proteins. This lyophilised vial from

Quanta Pharma

offers researchers a high-purity compound for advanced studies in tissue regeneration, gut health, and musculoskeletal recovery. Independently lab-verified across two laboratories, most recently by Analiza Białek at 99% purity and 4.85mg content. Available for

UK delivery

with fast dispatch.

Quanta Pharma BPC-157 Specifications

Peptide

BPC-157

Sequence

15 Amino Acids

Dosage

5mg/vial

Purity

Form

Lyophilised

Storage

2-8°C

BPC-157 5mg

Quanta Pharma

Quanta Pharma BPC-157 Research Benefits

Tissue regeneration

Gut health support

Joint recovery

Neuroprotective properties

Anti-inflammatory action

How Quanta Pharma BPC-157 Works

BPC-157

(Body Protection Compound-157) is a

synthetic pentadecapeptide

consisting of 15 amino acids. It is derived from a protective protein found naturally in human gastric juice, which contributes to gut mucosal integrity and tissue repair.

Quanta Pharma

produces this peptide to exacting pharmaceutical standards.

Research indicates BPC-157 works through multiple mechanisms including upregulation of growth hormone receptors, promotion of angiogenesis (new blood vessel formation), and modulation of the nitric oxide system. These pathways contribute to the remarkable tissue-healing properties observed in preclinical studies using

Quanta Pharma

Quanta Pharma BPC-157 vs TB-500

While both

BPC-157

TB-500

Quanta Pharma

are researched for tissue repair, they work through different mechanisms. BPC-157 primarily affects the GI tract and localised tissue healing, whilst TB-500 (Thymosin Beta-4) promotes systemic tissue repair and cell migration. Many researchers combine both

Quanta Pharma

peptides in protocols for comprehensive recovery studies.

Why Choose Quanta Pharma BPC-157?

Quanta Pharma

is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. Every batch of

Quanta Pharma BPC-157

undergoes rigorous quality control and independent third-party testing through Janoshik laboratories. This commitment to quality ensures researchers receive consistent, reliable compounds for their studies.

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:

Legal Notice:

This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.